# US 2002/0058706 A1 · Method for treating asthma using pregabalin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0058706 A1
- Document ID: US20020058706A1
- Status: Published application
- Kind: A1
- Application number: 09/952,447
- Filed: 2001-09-14
- Published: 2002-05-16
- Earliest claimed: 2000-09-22
- Inventors: Denis J. Schrier; Charles Price Taylor JR.
- Web page: https://patentgrep.com/patent/US20020058706A1

## CPC

- A61K 31/197: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K31/205)
- A61P 11/06: Antiasthmatics
- A61P 11/08: Bronchodilators
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention relates to a method for preventing asthma and related inflammatory disease in mammals. This invention also relates to a method for treating or alleviating the symptoms of asthma and related inflammatory disease in mammals.

## Claims

### Claim 1

A method of treating or alleviating the symptoms of asthma or related inflammatory disorders in an individual with a compound of Formula I
2
comprising administering to the individual a quantity of the compound sufficient to result in bronchodilation.

### Claim 2

A method of preventing asthma in an individual with a compound of Formula I
3
comprising administering to the individual a quantity of the compound sufficient to prevent bronchoconstriction.

### Claim 3 (depends on 1)

The method of claim 1, wherein the compound is pregabalin.

### Claim 4 (depends on 2)

The method of claim 2, wherein the compound is pregabalin.

### Claim 5 (depends on 1)

The method of claim 1, comprising administering to the individual by inhalation from approximately 25 mcg to approximately 50 mcg of the compound.

### Claim 6 (depends on 2)

The method of claim 2, comprising administering to the individual by inhalation from approximately 25 mcg to approximately 50 mcg of the compound.

### Claim 7 (depends on 1)

The method of claim 1 comprising orally administering to the individual from approximately 1 mg to approximately 8 mg of the compound 1 to 4 times daily.

### Claim 8 (depends on 2)

The method of claim 2 comprising orally administering to the individual from approximately 1 mg to approximately 8 mg of the compound 1 to 4 times daily.

### Claim 9 (depends on 1)

The method of claim 1, further comprising administering to the individual a quantity of the compound sufficient to result in bronchodilation and at least one additional drug.

### Claim 10 (depends on 2)

The method of claim 2, further comprising administering to the individual a quantity of the compound sufficient to result in bronchodilation and at least one additional drug.
